Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 66 entries
Sorted by: Best Match Show Resources per page
Corrigendum to "Pyridoxine-5'-phosphate oxidase (Pnpo) deficiency: Clinical and biochemical alterations associated with the C.347g>A (P.·Arg116gln) mutation" [Mol. Genet. Metab. 122/1-2 (2017) 135-142].

Molecular genetics and metabolism

di Salvo ML, Mastrangelo M, Nogués I, Tolve M, Paiardini A, Carducci C, Mei D, Montomoli M, Tramonti A, Guerrini R, Contestabile R, Leuzzi V.
PMID: 29548777
Mol Genet Metab. 2018 Dec;125(4):359. doi: 10.1016/j.ymgme.2018.02.017. Epub 2018 Mar 14.

No abstract available.

Cite
di Salvo ML, Mastrangelo M, Nogués I, et al. Corrigendum to "Pyridoxine-5'-phosphate oxidase (Pnpo) deficiency: Clinical and biochemical alterations associated with the C.347g>A (P.·Arg116gln) mutation" [Mol. Genet. Metab. 122/1-2 (2017) 135-142]. Mol Genet Metab. 2018;125(4):359doi: 10.1016/j.ymgme.2018.02.017.
di Salvo, M. L., Mastrangelo, M., Nogués, I., Tolve, M., Paiardini, A., Carducci, C., Mei, D., Montomoli, M., Tramonti, A., Guerrini, R., Contestabile, R., & Leuzzi, V. (2018). Corrigendum to "Pyridoxine-5'-phosphate oxidase (Pnpo) deficiency: Clinical and biochemical alterations associated with the C.347g>A (P.·Arg116gln) mutation" [Mol. Genet. Metab. 122/1-2 (2017) 135-142]. Molecular genetics and metabolism, 125(4), 359. https://doi.org/10.1016/j.ymgme.2018.02.017
di Salvo, Martino L, et al. "Corrigendum to "Pyridoxine-5'-phosphate oxidase (Pnpo) deficiency: Clinical and biochemical alterations associated with the C.347g>A (P.·Arg116gln) mutation" [Mol. Genet. Metab. 122/1-2 (2017) 135-142]." Molecular genetics and metabolism vol. 125,4 (2018): 359. doi: https://doi.org/10.1016/j.ymgme.2018.02.017
di Salvo ML, Mastrangelo M, Nogués I, Tolve M, Paiardini A, Carducci C, Mei D, Montomoli M, Tramonti A, Guerrini R, Contestabile R, Leuzzi V. Corrigendum to "Pyridoxine-5'-phosphate oxidase (Pnpo) deficiency: Clinical and biochemical alterations associated with the C.347g>A (P.·Arg116gln) mutation" [Mol. Genet. Metab. 122/1-2 (2017) 135-142]. Mol Genet Metab. 2018 Dec;125(4):359. doi: 10.1016/j.ymgme.2018.02.017. Epub 2018 Mar 14. PMID: 29548777.
Copy Download .nbib Format: NLM
Prediction and visualization data for the interpretation of sarcomeric and non-sarcomeric DNA variants found in patients with hypertrophic cardiomyopathy.

Data in brief

Bottillo I, D'Angelantonio D, Caputo V, Paiardini A, Lipari M, De Bernardo C, Majore S, Castori M, Zachara E, Re F, Grammatico P.
PMID: 27054166
Data Brief. 2016 Mar 10;7:607-13. doi: 10.1016/j.dib.2016.03.004. eCollection 2016 Jun.

Genomic technologies are redefining the understanding of genotype-phenotype relationships and over the past decade, many bioinformatics algorithms have been developed to predict functional consequences of single nucleotide variants. This article presents the data from a comprehensive computational workflow adopted...

Cite
Bottillo I, D'Angelantonio D, Caputo V, et al. Prediction and visualization data for the interpretation of sarcomeric and non-sarcomeric DNA variants found in patients with hypertrophic cardiomyopathy. Data Brief. 2016;7:607-13doi: 10.1016/j.dib.2016.03.004.
Bottillo, I., D'Angelantonio, D., Caputo, V., Paiardini, A., Lipari, M., De Bernardo, C., Majore, S., Castori, M., Zachara, E., Re, F., & Grammatico, P. (2016). Prediction and visualization data for the interpretation of sarcomeric and non-sarcomeric DNA variants found in patients with hypertrophic cardiomyopathy. Data in brief, 7607-13. https://doi.org/10.1016/j.dib.2016.03.004
Bottillo, Irene, et al. "Prediction and visualization data for the interpretation of sarcomeric and non-sarcomeric DNA variants found in patients with hypertrophic cardiomyopathy." Data in brief vol. 7 (2016): 607-13. doi: https://doi.org/10.1016/j.dib.2016.03.004
Bottillo I, D'Angelantonio D, Caputo V, Paiardini A, Lipari M, De Bernardo C, Majore S, Castori M, Zachara E, Re F, Grammatico P. Prediction and visualization data for the interpretation of sarcomeric and non-sarcomeric DNA variants found in patients with hypertrophic cardiomyopathy. Data Brief. 2016 Mar 10;7:607-13. doi: 10.1016/j.dib.2016.03.004. eCollection 2016 Jun. PMID: 27054166; PMCID: PMC4802523.
Copy Download .nbib Format: NLM
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide.

Therapeutics and clinical risk management

Braido F, Lagasio C, Piroddi I, Baiardini I, Canonica G.
PMID: 18728855
Ther Clin Risk Manag. 2008 Apr;4(2):353-61. doi: 10.2147/tcrm.s1266.

Allergic rhinitis (AR) is a chronic inflammatory respiratory disease affecting 5%-50% of the worldwide population and its prevalence is increasing (Herman 2007). In addition, AR is associated with asthma and other co-morbidities such as conjunctivitis and sinusitis. The main...

Cite
Braido F, Lagasio C, Piroddi I, et al. New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. Ther Clin Risk Manag. 2008;4(2):353-61doi: 10.2147/tcrm.s1266.
Braido, F., Lagasio, C., Piroddi, I., Baiardini, I., & Canonica, G. (2008). New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. Therapeutics and clinical risk management, 4(2), 353-61. https://doi.org/10.2147/tcrm.s1266
Braido, F, et al. "New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide." Therapeutics and clinical risk management vol. 4,2 (2008): 353-61. doi: https://doi.org/10.2147/tcrm.s1266
Braido F, Lagasio C, Piroddi I, Baiardini I, Canonica G. New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. Ther Clin Risk Manag. 2008 Apr;4(2):353-61. doi: 10.2147/tcrm.s1266. PMID: 18728855; PMCID: PMC2504079.
Copy Download .nbib Format: NLM
Microbial translocation and infectious diseases: what is the link?.

International journal of microbiology

D'Ettorre G, Douek D, Paiardini M, Ceccarelli G, Vullo V.
PMID: 23091494
Int J Microbiol. 2012;2012:356981. doi: 10.1155/2012/356981. Epub 2012 Oct 04.

No abstract available.

Cite
D'Ettorre G, Douek D, Paiardini M, et al. Microbial translocation and infectious diseases: what is the link?. Int J Microbiol. 2012;2012:356981doi: 10.1155/2012/356981.
D'Ettorre, G., Douek, D., Paiardini, M., Ceccarelli, G., & Vullo, V. (2012). Microbial translocation and infectious diseases: what is the link?. International journal of microbiology, 2012356981. https://doi.org/10.1155/2012/356981
D'Ettorre, Gabriella, et al. "Microbial translocation and infectious diseases: what is the link?." International journal of microbiology vol. 2012 (2012): 356981. doi: https://doi.org/10.1155/2012/356981
D'Ettorre G, Douek D, Paiardini M, Ceccarelli G, Vullo V. Microbial translocation and infectious diseases: what is the link?. Int J Microbiol. 2012;2012:356981. doi: 10.1155/2012/356981. Epub 2012 Oct 04. PMID: 23091494; PMCID: PMC3471423.
Copy Download .nbib Format: NLM
Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives.

Patient related outcome measures

Padilla Galo A, Labor M, Tiotiu A, Baiardini I, Scichilone N, Braido F.
PMID: 30147386
Patient Relat Outcome Meas. 2018 Aug 17;9:267-273. doi: 10.2147/PROM.S146966. eCollection 2018.

Approximately 5%-10% of asthmatics suffer from severe asthma. New biological treatments represent a great opportunity to reduce asthma burden and to improve asthma patients' lives. Reslizumab will soon be available in several European countries. This anti-IL-5 IgG4/κ monoclonal antibody,...

Cite
Padilla Galo A, Labor M, Tiotiu A, et al. Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives. Patient Relat Outcome Meas. 2018;9:267-273doi: 10.2147/PROM.S146966.
Padilla Galo, A., Labor, M., Tiotiu, A., Baiardini, I., Scichilone, N., & Braido, F. (2018). Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives. Patient related outcome measures, 9267-273. https://doi.org/10.2147/PROM.S146966
Padilla Galo, Alicia, et al. "Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives." Patient related outcome measures vol. 9 (2018): 267-273. doi: https://doi.org/10.2147/PROM.S146966
Padilla Galo A, Labor M, Tiotiu A, Baiardini I, Scichilone N, Braido F. Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives. Patient Relat Outcome Meas. 2018 Aug 17;9:267-273. doi: 10.2147/PROM.S146966. eCollection 2018. PMID: 30147386; PMCID: PMC6103306.
Copy Download .nbib Format: NLM
N.

Frontiers in oncology

Ianniello Z, Paiardini A, Fatica A.
PMID: 31024852
Front Oncol. 2019 Apr 09;9:251. doi: 10.3389/fonc.2019.00251. eCollection 2019.

Recent studies have uncovered an important role for RNA modifications in gene expression regulation, which led to the birth of the epitranscriptomics field. It is now acknowledged that RNA modifiers play a crucial role in the control of differentiation...

Cite
Ianniello Z, Paiardini A, Fatica A. N. Front Oncol. 2019;9:251doi: 10.3389/fonc.2019.00251.
Ianniello, Z., Paiardini, A., & Fatica, A. (2019). N. Frontiers in oncology, 9251. https://doi.org/10.3389/fonc.2019.00251
Ianniello, Zaira, et al. "N." Frontiers in oncology vol. 9 (2019): 251. doi: https://doi.org/10.3389/fonc.2019.00251
Ianniello Z, Paiardini A, Fatica A. N. Front Oncol. 2019 Apr 09;9:251. doi: 10.3389/fonc.2019.00251. eCollection 2019. PMID: 31024852; PMCID: PMC6465620.
Copy Download .nbib Format: NLM
CD8 lymphocyte depletion enhances the latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques.

Journal of virology

Mavigner M, Liao LE, Brooks AD, Ke R, Mattingly C, Schoof N, McBrien J, Carnathan D, Liang S, Vanderford TH, Paiardini M, Kulpa D, Lifson JD, Dunham RM, Easley KA, Margolis DM, Perelson AS, Silvestri G, Chahroudi A.
PMID: 33568515
J Virol. 2021 Feb 10; doi: 10.1128/JVI.01429-20. Epub 2021 Feb 10.

Inducing latency reversal to reveal infected cells to the host immune system represents a potential strategy to cure HIV infection. In separate studies, we have previously shown that CD8

Cite
Mavigner M, Liao LE, Brooks AD, et al. CD8 lymphocyte depletion enhances the latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques. J Virol. 2021;doi: 10.1128/JVI.01429-20.
Mavigner, M., Liao, L. E., Brooks, A. D., Ke, R., Mattingly, C., Schoof, N., McBrien, J., Carnathan, D., Liang, S., Vanderford, T. H., Paiardini, M., Kulpa, D., Lifson, J. D., Dunham, R. M., Easley, K. A., Margolis, D. M., Perelson, A. S., Silvestri, G., & Chahroudi, A. (2021). CD8 lymphocyte depletion enhances the latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques. Journal of virology, . https://doi.org/10.1128/JVI.01429-20
Mavigner, Maud, et al. "CD8 lymphocyte depletion enhances the latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques." Journal of virology vol. (2021). doi: https://doi.org/10.1128/JVI.01429-20
Mavigner M, Liao LE, Brooks AD, Ke R, Mattingly C, Schoof N, McBrien J, Carnathan D, Liang S, Vanderford TH, Paiardini M, Kulpa D, Lifson JD, Dunham RM, Easley KA, Margolis DM, Perelson AS, Silvestri G, Chahroudi A. CD8 lymphocyte depletion enhances the latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques. J Virol. 2021 Feb 10; doi: 10.1128/JVI.01429-20. Epub 2021 Feb 10. PMID: 33568515; PMCID: PMC8103677.
Copy Download .nbib Format: NLM
PHA-680626 Is an Effective Inhibitor of the Interaction between Aurora-A and N-Myc.

International journal of molecular sciences

Boi D, Souvalidou F, Capelli D, Polverino F, Marini G, Montanari R, Pochetti G, Tramonti A, Contestabile R, Trisciuoglio D, Carpinelli P, Ascanelli C, Lindon C, De Leo A, Saviano M, Di Santo R, Costi R, Guarguaglini G, Paiardini A.
PMID: 34884931
Int J Mol Sci. 2021 Dec 04;22(23). doi: 10.3390/ijms222313122.

Neuroblastoma is a severe childhood disease, accounting for ~10% of all infant cancers. The amplification of the MYCN gene, coding for the N-Myc transcription factor, is an essential marker correlated with tumor progression and poor prognosis. In neuroblastoma cells,...

Cite
Boi D, Souvalidou F, Capelli D, et al. PHA-680626 Is an Effective Inhibitor of the Interaction between Aurora-A and N-Myc. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222313122.
Boi, D., Souvalidou, F., Capelli, D., Polverino, F., Marini, G., Montanari, R., Pochetti, G., Tramonti, A., Contestabile, R., Trisciuoglio, D., Carpinelli, P., Ascanelli, C., Lindon, C., De Leo, A., Saviano, M., Di Santo, R., Costi, R., Guarguaglini, G., & Paiardini, A. (2021). PHA-680626 Is an Effective Inhibitor of the Interaction between Aurora-A and N-Myc. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222313122
Boi, Dalila, et al. "PHA-680626 Is an Effective Inhibitor of the Interaction between Aurora-A and N-Myc." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222313122
Boi D, Souvalidou F, Capelli D, Polverino F, Marini G, Montanari R, Pochetti G, Tramonti A, Contestabile R, Trisciuoglio D, Carpinelli P, Ascanelli C, Lindon C, De Leo A, Saviano M, Di Santo R, Costi R, Guarguaglini G, Paiardini A. PHA-680626 Is an Effective Inhibitor of the Interaction between Aurora-A and N-Myc. Int J Mol Sci. 2021 Dec 04;22(23). doi: 10.3390/ijms222313122. PMID: 34884931.
Copy Download .nbib Format: NLM
Evaluation of Exposure to Toluene and Xylene in Gasoline Station Workers.

Advances in preventive medicine

Geraldino BR, Nunes RFN, Gomes JB, da Poça KS, Giardini I, Silva PVB, Souza HP, Otero UB, Sarpa M.
PMID: 34104483
Adv Prev Med. 2021 May 20;2021:5553633. doi: 10.1155/2021/5553633. eCollection 2021.

The main volatile organic compounds found at gasoline stations are benzene, toluene, ethylbenzene, and xylene isomers (BTEX). They cause several harmful effects on human health. Regulatory Norm 7 (1978) provides that, in Brazil, biological monitoring of toluene and xylene...

Cite
Geraldino BR, Nunes RFN, Gomes JB, et al. Evaluation of Exposure to Toluene and Xylene in Gasoline Station Workers. Adv Prev Med. 2021;2021:5553633doi: 10.1155/2021/5553633.
Geraldino, B. R., Nunes, R. F. N., Gomes, J. B., da Poça, K. S., Giardini, I., Silva, P. V. B., Souza, H. P., Otero, U. B., & Sarpa, M. (2021). Evaluation of Exposure to Toluene and Xylene in Gasoline Station Workers. Advances in preventive medicine, 20215553633. https://doi.org/10.1155/2021/5553633
Geraldino, Barbara R, et al. "Evaluation of Exposure to Toluene and Xylene in Gasoline Station Workers." Advances in preventive medicine vol. 2021 (2021): 5553633. doi: https://doi.org/10.1155/2021/5553633
Geraldino BR, Nunes RFN, Gomes JB, da Poça KS, Giardini I, Silva PVB, Souza HP, Otero UB, Sarpa M. Evaluation of Exposure to Toluene and Xylene in Gasoline Station Workers. Adv Prev Med. 2021 May 20;2021:5553633. doi: 10.1155/2021/5553633. eCollection 2021. PMID: 34104483; PMCID: PMC8159630.
Copy Download .nbib Format: NLM
Intronic Determinants Coordinate Charme lncRNA Nuclear Activity through the Interaction with MATR3 and PTBP1.

Cell reports

Desideri F, Cipriano A, Petrezselyova S, Buonaiuto G, Santini T, Kasparek P, Prochazka J, Janson G, Paiardini A, Calicchio A, Colantoni A, Sedlacek R, Bozzoni I, Ballarino M.
PMID: 33357424
Cell Rep. 2020 Dec 22;33(12):108548. doi: 10.1016/j.celrep.2020.108548.

Chromatin architect of muscle expression (Charme) is a muscle-restricted long noncoding RNA (lncRNA) that plays an important role in myogenesis. Earlier evidence indicates that the nuclear Charme isoform, named pCharme, acts on the chromatin by assisting the formation of...

Cite
Desideri F, Cipriano A, Petrezselyova S, et al. Intronic Determinants Coordinate Charme lncRNA Nuclear Activity through the Interaction with MATR3 and PTBP1. Cell Rep. 2020;33(12):108548doi: 10.1016/j.celrep.2020.108548.
Desideri, F., Cipriano, A., Petrezselyova, S., Buonaiuto, G., Santini, T., Kasparek, P., Prochazka, J., Janson, G., Paiardini, A., Calicchio, A., Colantoni, A., Sedlacek, R., Bozzoni, I., & Ballarino, M. (2020). Intronic Determinants Coordinate Charme lncRNA Nuclear Activity through the Interaction with MATR3 and PTBP1. Cell reports, 33(12), 108548. https://doi.org/10.1016/j.celrep.2020.108548
Desideri, Fabio, et al. "Intronic Determinants Coordinate Charme lncRNA Nuclear Activity through the Interaction with MATR3 and PTBP1." Cell reports vol. 33,12 (2020): 108548. doi: https://doi.org/10.1016/j.celrep.2020.108548
Desideri F, Cipriano A, Petrezselyova S, Buonaiuto G, Santini T, Kasparek P, Prochazka J, Janson G, Paiardini A, Calicchio A, Colantoni A, Sedlacek R, Bozzoni I, Ballarino M. Intronic Determinants Coordinate Charme lncRNA Nuclear Activity through the Interaction with MATR3 and PTBP1. Cell Rep. 2020 Dec 22;33(12):108548. doi: 10.1016/j.celrep.2020.108548. PMID: 33357424; PMCID: PMC7773549.
Copy Download .nbib Format: NLM
From PARP1 to TNKS2 Inhibition: A Structure-Based Approach.

ACS medicinal chemistry letters

Tomassi S, Pfahler J, Mautone N, Rovere A, Esposito C, Passeri D, Pellicciari R, Novellino E, Pannek M, Steegborn C, Paiardini A, Mai A, Rotili D.
PMID: 32435397
ACS Med Chem Lett. 2020 Feb 03;11(5):862-868. doi: 10.1021/acsmedchemlett.9b00654. eCollection 2020 May 14.

Tankyrases (TNKSs) have recently gained great consideration as potential targets in Wnt/β-catenin pathway-dependent solid tumors. Previously, we reported the 2-mercaptoquinazolin-4-one MC2050 as a micromolar PARP1 inhibitor. Here we show how the resolution of the X-ray structure of PARP1 in...

Cite
Tomassi S, Pfahler J, Mautone N, et al. From PARP1 to TNKS2 Inhibition: A Structure-Based Approach. ACS Med Chem Lett. 2020;11(5):862-868doi: 10.1021/acsmedchemlett.9b00654.
Tomassi, S., Pfahler, J., Mautone, N., Rovere, A., Esposito, C., Passeri, D., Pellicciari, R., Novellino, E., Pannek, M., Steegborn, C., Paiardini, A., Mai, A., & Rotili, D. (2020). From PARP1 to TNKS2 Inhibition: A Structure-Based Approach. ACS medicinal chemistry letters, 11(5), 862-868. https://doi.org/10.1021/acsmedchemlett.9b00654
Tomassi, Stefano, et al. "From PARP1 to TNKS2 Inhibition: A Structure-Based Approach." ACS medicinal chemistry letters vol. 11,5 (2020): 862-868. doi: https://doi.org/10.1021/acsmedchemlett.9b00654
Tomassi S, Pfahler J, Mautone N, Rovere A, Esposito C, Passeri D, Pellicciari R, Novellino E, Pannek M, Steegborn C, Paiardini A, Mai A, Rotili D. From PARP1 to TNKS2 Inhibition: A Structure-Based Approach. ACS Med Chem Lett. 2020 Feb 03;11(5):862-868. doi: 10.1021/acsmedchemlett.9b00654. eCollection 2020 May 14. PMID: 32435397; PMCID: PMC7236224.
Copy Download .nbib Format: NLM
Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in the Polish population.

Postepy dermatologii i alergologii

Kupczyk M, Baiardini I, Molinengo G, Loera B, Szydłowska D, Kuna P, Canonica GW, Braido F.
PMID: 32467692
Postepy Dermatol Alergol. 2020 Feb;37(1):97-102. doi: 10.5114/ada.2020.93387. Epub 2020 Mar 09.

INTRODUCTION: The RhinAsthma Patient Perspective (RAPP) was developed in Italian to assess the Health Related Quality of Life (HRQoL) impairment in patients with asthma and allergic rhinitis (AR) in daily practice.AIM: To cross-culturally validate the Polish version.MATERIAL AND METHODS:...

Cite
Kupczyk M, Baiardini I, Molinengo G, et al. Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in the Polish population. Postepy Dermatol Alergol. 2020;37(1):97-102doi: 10.5114/ada.2020.93387.
Kupczyk, M., Baiardini, I., Molinengo, G., Loera, B., Szydłowska, D., Kuna, P., Canonica, G. W., & Braido, F. (2020). Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in the Polish population. Postepy dermatologii i alergologii, 37(1), 97-102. https://doi.org/10.5114/ada.2020.93387
Kupczyk, Maciej, et al. "Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in the Polish population." Postepy dermatologii i alergologii vol. 37,1 (2020): 97-102. doi: https://doi.org/10.5114/ada.2020.93387
Kupczyk M, Baiardini I, Molinengo G, Loera B, Szydłowska D, Kuna P, Canonica GW, Braido F. Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in the Polish population. Postepy Dermatol Alergol. 2020 Feb;37(1):97-102. doi: 10.5114/ada.2020.93387. Epub 2020 Mar 09. PMID: 32467692; PMCID: PMC7247060.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 66 entries